BIOMAT Database Logo BIOMAT Database Logo

Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion. 2010

Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Clinical Hemostaseology and Transfusion Medicine University Hospital Düsseldorf, Moorenstr 5, 40225 Düsseldorf, Germany. giers@uni-duesseldorf.de

BACKGROUND Different therapeutic approaches have been used in fetal-neonatal alloimmune thrombocytopenia, but many centers administer immunoglobulin G infusions to the pregnant woman. We studied the effect of maternal antenatal immunoglobulin infusions on fetal platelet counts in pregnancies with fetal alloimmune thrombocytopenia. METHODS We retrospectively analyzed the clinical courses of fetuses with fetal alloimmune thrombocytopenia whose mothers were treated with immunoglobulin G infusions in a single center between 1999 and 2005. In a center-specific protocol, weekly maternal immunoglobulin G infusions were given to 25 pregnant women with previously affected neonates and four women with strong platelet antibodies, but no previous history of fetal alloimmune thrombocytopenia; before each infusion diagnostic fetal blood sampling was performed to determine fetal platelet counts and immunoglobulin G levels. RESULTS There were 30 fetuses with fetal alloimmune thrombocytopenia, confirmed by initial fetal blood sampling showing fetal platelet counts between 4×10(9)/L and 130×10(9)/L and antibody-coated fetal platelets using a glycoprotein specific assay. Despite weekly antenatal maternal immunoglobulin G infusions fetal platelet counts did not change significantly. Maternal and fetal immunoglobulin G levels, measured before every infusion, increased significantly with the number of maternal immunoglobulin G infusions. CONCLUSIONS In this group of fetuses with fetal alloimmune thrombocytopenia no consistent increase of fetal platelets was achieved as a result of regular maternal immunoglobulin G infusions.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I

Related Publications

Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia.
February 2013, Obstetrics and gynecology,
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Intravenous fetal transfusion of immunoglobulin for alloimmune thrombocytopenia.
October 1992, Lancet (London, England),
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia.
December 1994, Transfusion medicine (Oxford, England),
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Intravenous immunoglobulin g therapy in fetal and neonatal alloimmune thrombocytopenia.
October 1997, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Intravenous immunoglobulin for neonatal alloimmune thrombocytopenia.
May 1988, The Journal of pediatrics,
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.
January 2015, Blood transfusion = Trasfusione del sangue,
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
[Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
September 2007, Journal de gynecologie, obstetrique et biologie de la reproduction,
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
The fetal and neonatal consequences of maternal alloimmune thrombocytopenia.
June 1998, Bailliere's clinical haematology,
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
In-utero fetal therapy with immunoglobulin for alloimmune thrombocytopenia.
September 1992, Lancet (London, England),
Günther Giers, and Folker Wenzel, and Markus Stockschläder, and Regina Riethmacher, and Horst Lorenz, and Boris Tutschek
Fetal alloimmune thrombocytopenia.
July 1997, The New England journal of medicine,
Copied contents to your clipboard!